Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02708875
Other study ID # H14086
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date December 2021

Study information

Verified date April 2021
Source Menzies Institute for Medical Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Insulin resistance (or pre-diabetes) is diagnosed using the oral glucose tolerance test. However, high blood glucose levels during this test may adversely impact on microvascular function. Investigators will determine whether a liquid mixed meal challenge (from carbohydrate, protein and fat) is a more appropriate test for assessing microvascular-derived insulin resistance.


Description:

After consuming a meal, 80% of glucose is disposed in skeletal muscle. Our research group has demonstrated that microvascular blood flow in skeletal muscle plays an integral role in this process. Physiological doses of insulin stimulate microvascular blood flow, and that this increase is associated with enhanced glucose uptake by muscle. This microvascular action of insulin is lost during insulin resistance and type 2 diabetes. The oral glucose tolerance test (GTT) is the gold standard for assessing insulin resistance and pre-diabetes and is used world-wide. However high blood glucose levels following a glucose load may adversely impact on microvascular function. The aim of this project is to determine whether a mixed meal challenge (liquid drink consisting of carbohydrate, fat and protein) is a better test for assessing microvascular-derived insulin resistance.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 45
Est. completion date December 2021
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Aged 18-70 years. - Normal to overweight (BMI 19-35 kg/m2). - Normotensive (Seated brachial blood pressure <160/100 mmHg). - Considered healthy (HbA1c <6.5 %) or have clinically diagnosed type 2 diabetes. - Either have a parent with T2D, or no family history of type 2 diabetes for two generations. - Have given signed informed consent to participate in the study Exclusion Criteria: - Age <18 yrs or >70 yrs - Morbidly obese with a BMI =36 kg/m2 - History of myocardial infarction or stroke - History of malignancy within past 5 years (except for non-melanoma skin cancers) - Current smoker - History of severe liver disease - History of drug or alcohol abuse - Elective major surgery during the course of the study - Pregnancy/lactation - Participation or intention to participate in another clinical research study during the study period.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mixed Meal Challenge
Liquid mixed meal (300 calories - fat, carbohydrate, and protein).
Glucose Challenge
Glucose drink (50g glucose)

Locations

Country Name City State
Australia Deakin University Burwood Victoria
Australia Menzies Institute for Medical Research Hobart Tasmania

Sponsors (2)

Lead Sponsor Collaborator
Menzies Institute for Medical Research Deakin University

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in muscle microvascular blood flow Microvascular responses will be measured by contrast enhanced ultrasound before and 1hr after each challenge. 1 hr
Secondary Changes in blood glucose levels Blood glucose levels will be measured at 0, 15, 30, 60, 90 and 120 min following each challenge. 2 hr
Secondary Changes in plasma insulin levels Plasma insulin levels will be measured at 0, 15, 30, 60, 90 and 120 min following each challenge. 2hr
Secondary Changes in the respiratory exchange ratio (RER) Changes in RER will be measured by metabolic cart during each challenge. 1 hr
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03383822 - Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04203238 - Potato Research for Enhancing Metabolic Outcomes N/A
Recruiting NCT03658564 - Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance N/A
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03627104 - Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Active, not recruiting NCT03288025 - Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT01809288 - Identifying Risk for Diabetes and Heart Disease in Women
Completed NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Withdrawn NCT04741204 - Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Phase 4
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A